210 related articles for article (PubMed ID: 21838308)
1. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
2. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
Aliabadi HM; Mahdipoor P; Uludağ H
Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
[TBL] [Abstract][Full Text] [Related]
3. Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.
Aliabadi HM; Landry B; Mahdipoor P; Hsu CY; Uludağ H
Eur J Pharm Biopharm; 2012 May; 81(1):33-42. PubMed ID: 22311298
[TBL] [Abstract][Full Text] [Related]
4. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
[TBL] [Abstract][Full Text] [Related]
5. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
[TBL] [Abstract][Full Text] [Related]
6. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery.
Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
Curr Pharm Des; 2017; 23(16):2400-2409. PubMed ID: 27799034
[TBL] [Abstract][Full Text] [Related]
8. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles.
Yang Y; Gao Y; Chen L; Huang Y; Li Y
Int J Pharm; 2011 Feb; 405(1-2):188-95. PubMed ID: 21130850
[TBL] [Abstract][Full Text] [Related]
10. Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
Biologicals; 2016 Nov; 44(6):487-496. PubMed ID: 27712979
[TBL] [Abstract][Full Text] [Related]
11. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
[TBL] [Abstract][Full Text] [Related]
13. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
Shen J; Yin Q; Chen L; Zhang Z; Li Y
Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221
[TBL] [Abstract][Full Text] [Related]
16. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
Croci DO; Cogno IS; Vittar NB; Salvatierra E; Trajtenberg F; Podhajcer OL; Osinaga E; Rabinovich GA; Rivarola VA
J Cell Biochem; 2008 Oct; 105(2):381-90. PubMed ID: 18553460
[TBL] [Abstract][Full Text] [Related]
17. Highly stable polyglutamate derivatives/siRNA polyplex efficiently down-relegate survivin expression and augment the efficacy of cisplatin.
Wang Z; Zou H; Wang Z; Wu J; Xia Z; Feng M
Int J Pharm; 2016 May; 505(1-2):24-34. PubMed ID: 27039150
[TBL] [Abstract][Full Text] [Related]
18. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association.
Lee E; Oh C; Kim IS; Kwon IC; Kim S
J Control Release; 2015 Jul; 210():105-14. PubMed ID: 25979325
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]